VERTEX PHARMACEUTICALS INC / MA Selling, General and Administrative Expense
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Selling, General and Administrative Expense of $582.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for the quarter ending 2026-06-30 was $582.20M, a 37.12% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for the quarter ending 2026-03-31 was $493.70M, a 24.55% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for the quarter ending 2025-12-31 was $487.00M, a 28.97% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for the quarter ending 2025-09-30 was $445.10M, a 19.71% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for fiscal 2025 was $1.75B, a 19.72% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for fiscal 2024 was $1.46B, a 28.83% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for fiscal 2023 was $1.14B, a 20.31% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA selling, general and administrative expense for fiscal 2022 was $944.70M, a 12.45% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $582.20M 10-Q · filed 2026-08-04 | $1.08B 10-Q · filed 2026-08-04 | $1.56B derived: sum of 3 quarters · filed 2026-08-04 | $2.01B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $493.70M 10-Q · filed 2026-05-05 | $980.70M derived: sum of 2 quarters · filed 2026-05-05 | $1.43B derived: sum of 3 quarters · filed 2026-05-05 | $1.85B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $487.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $932.10M derived: sum of 2 quarters · filed 2026-02-13 | $1.36B derived: sum of 3 quarters · filed 2026-08-04 | $1.75B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $445.10M 10-Q · filed 2025-11-04 | $869.70M derived: sum of 2 quarters · filed 2026-08-04 | $1.27B 10-Q · filed 2025-11-04 | $1.64B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $424.60M 10-Q · filed 2026-08-04 | $821.00M 10-Q · filed 2026-08-04 | $1.20B derived: sum of 3 quarters · filed 2026-08-04 | $1.57B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $396.40M 10-Q · filed 2026-05-05 | $774.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.15B derived: sum of 3 quarters · filed 2026-05-05 | $1.52B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $377.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $749.40M derived: sum of 2 quarters · filed 2026-02-13 | $1.12B derived: sum of 3 quarters · filed 2026-02-13 | $1.46B 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $371.80M 10-Q · filed 2025-11-04 | $744.00M derived: sum of 2 quarters · filed 2025-11-04 | $1.09B 10-Q · filed 2025-11-04 | $1.46B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $372.20M 10-Q · filed 2025-08-05 | $714.90M 10-Q · filed 2025-08-05 | $1.08B derived: sum of 3 quarters · filed 2026-02-13 | $1.35B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $342.70M 10-Q · filed 2025-05-06 | $711.80M derived: sum of 2 quarters · filed 2026-02-13 | $975.60M derived: sum of 3 quarters · filed 2026-02-13 | $1.24B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $369.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $632.90M derived: sum of 2 quarters · filed 2026-02-13 | $895.50M derived: sum of 3 quarters · filed 2026-02-13 | $1.14B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $263.80M 10-Q · filed 2024-11-05 | $526.40M derived: sum of 2 quarters · filed 2024-11-05 | $767.50M 10-Q · filed 2024-11-05 | $1.03B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $262.60M 10-Q · filed 2024-08-02 | $503.70M 10-Q · filed 2024-08-02 | $771.10M derived: sum of 3 quarters · filed 2025-02-13 | $1.02B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $241.10M 10-Q · filed 2024-05-07 | $508.50M derived: sum of 2 quarters · filed 2025-02-13 | $755.30M derived: sum of 3 quarters · filed 2025-02-13 | $970.60M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $267.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $514.20M derived: sum of 2 quarters · filed 2025-02-13 | $729.50M derived: sum of 3 quarters · filed 2025-02-13 | $944.70M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $246.80M 10-Q · filed 2023-11-07 | $462.10M derived: sum of 2 quarters · filed 2023-11-07 | $677.30M 10-Q · filed 2023-11-07 | $932.50M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $215.30M 10-Q · filed 2023-08-02 | $430.50M 10-Q · filed 2023-08-02 | $685.70M derived: sum of 3 quarters · filed 2024-02-15 | $883.90M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $215.20M 10-Q · filed 2023-05-02 | $470.40M derived: sum of 2 quarters · filed 2024-02-15 | $668.60M derived: sum of 3 quarters · filed 2024-02-15 | $863.20M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $255.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $453.40M derived: sum of 2 quarters · filed 2024-02-15 | $648.00M derived: sum of 3 quarters · filed 2024-02-15 | $840.10M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $198.20M 10-Q · filed 2022-10-28 | $198.19M 10-Q · filed 2021-11-03 | $392.80M derived: sum of 2 quarters · filed 2022-10-28 | $584.90M 10-Q · filed 2022-10-28 | $584.93M 10-Q · filed 2021-11-03 | $796.74M derived: sum of 4 quarters · filed 2022-10-28 | ||
| 2021-06-30 | $194.60M 10-Q · filed 2022-08-05 | $194.67M 10-Q · filed 2021-07-30 | $386.70M 10-Q · filed 2022-08-05 | $386.75M 10-Q · filed 2021-07-30 | $598.54M derived: sum of 3 quarters · filed 2022-08-05 | $783.09M derived: sum of 4 quarters · filed 2022-08-05 | ||
| 2021-03-31 | $192.10M 10-Q · filed 2022-05-06 | $192.08M 10-Q · filed 2021-04-30 | $403.94M derived: sum of 2 quarters · filed 2022-05-06 | $588.49M derived: sum of 3 quarters · filed 2022-05-06 | $780.30M derived: sum of 4 quarters · filed 2022-05-06 | |||
| 2020-12-31 | $211.84M 10-K · filed 2021-02-11 | $396.39M derived: sum of 2 quarters · filed 2021-11-03 | $588.20M derived: sum of 3 quarters · filed 2021-11-03 | $770.50M 10-K · filed 2023-02-10 | $770.46M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $184.55M 10-Q · filed 2021-11-03 | $376.36M derived: sum of 2 quarters · filed 2021-11-03 | $558.61M 10-Q · filed 2021-11-03 | $753.89M derived: sum of 4 quarters · filed 2021-11-03 | ||||
| 2020-06-30 | $191.80M 10-Q · filed 2021-07-30 | $374.06M 10-Q · filed 2021-07-30 | $569.34M derived: sum of 3 quarters · filed 2021-07-30 | $729.01M derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2020-03-31 | $182.26M 10-Q · filed 2021-04-30 | $377.54M derived: sum of 2 quarters · filed 2021-04-30 | $537.21M derived: sum of 3 quarters · filed 2021-04-30 | $693.71M derived: sum of 4 quarters · filed 2021-04-30 | ||||
| 2019-12-31 | $195.28M 10-K · filed 2021-02-11 | $354.95M derived: sum of 2 quarters · filed 2021-02-11 | $511.45M derived: sum of 3 quarters · filed 2021-02-11 | $658.50M 10-K · filed 2022-02-09 | $658.50M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $159.67M 10-K · filed 2021-02-11 | $316.18M derived: sum of 2 quarters · filed 2021-02-11 | $463.22M 10-Q · filed 2020-10-30 | $616.43M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $156.50M 10-K · filed 2021-02-11 | $303.55M 10-Q · filed 2020-07-31 | $456.76M derived: sum of 3 quarters · filed 2021-02-11 | $594.05M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $147.04M 10-K · filed 2021-02-11 | $300.25M derived: sum of 2 quarters · filed 2021-02-11 | $437.55M derived: sum of 3 quarters · filed 2021-02-11 | $574.85M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $153.21M 10-K · filed 2020-02-13 | $290.50M derived: sum of 2 quarters · filed 2020-02-13 | $427.81M derived: sum of 3 quarters · filed 2020-02-13 | $557.62M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $137.29M 10-K · filed 2020-02-13 | $274.60M derived: sum of 2 quarters · filed 2020-02-13 | $404.41M 10-Q · filed 2019-10-31 | $539.20M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $137.30M 10-K · filed 2020-02-13 | $267.11M 10-Q · filed 2019-08-01 | $401.90M derived: sum of 3 quarters · filed 2020-02-13 | $522.62M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $129.81M 10-K · filed 2020-02-13 | $264.60M derived: sum of 2 quarters · filed 2020-02-13 | $385.31M derived: sum of 3 quarters · filed 2020-02-13 | $512.56M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $134.79M 10-K · filed 2019-02-13 | $255.50M derived: sum of 2 quarters · filed 2019-02-13 | $382.75M derived: sum of 3 quarters · filed 2019-02-13 | $496.08M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $120.71M 10-K · filed 2019-02-13 | $247.96M derived: sum of 2 quarters · filed 2019-02-13 | $361.29M 10-Q · filed 2018-10-25 | $471.19M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $127.25M 10-K · filed 2019-02-13 | $240.57M 10-Q · filed 2018-07-26 | $350.48M derived: sum of 3 quarters · filed 2019-02-13 | $456.54M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $113.33M 10-K · filed 2019-02-13 | $223.23M derived: sum of 2 quarters · filed 2019-02-13 | $329.29M derived: sum of 3 quarters · filed 2019-02-13 | $440.94M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $109.91M 10-K · filed 2018-02-15 | $215.96M derived: sum of 2 quarters · filed 2018-02-15 | $327.62M derived: sum of 3 quarters · filed 2018-02-15 | $432.83M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $106.06M 10-K · filed 2018-02-15 | $217.71M derived: sum of 2 quarters · filed 2018-02-15 | $322.92M 10-Q · filed 2017-10-30 | $419.47M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $111.65M 10-K · filed 2018-02-15 | $216.87M 10-Q · filed 2017-07-28 | $313.42M derived: sum of 3 quarters · filed 2018-02-15 | $413.19M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $105.21M 10-K · filed 2018-02-15 | $201.76M derived: sum of 2 quarters · filed 2018-02-15 | $301.54M derived: sum of 3 quarters · filed 2018-02-15 | $395.93M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $96.55M 10-K · filed 2017-02-23 | $196.32M derived: sum of 2 quarters · filed 2017-02-23 | $290.71M derived: sum of 3 quarters · filed 2017-02-23 | $376.57M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $99.77M 10-K · filed 2017-02-23 | $194.17M derived: sum of 2 quarters · filed 2017-02-23 | $280.03M 10-Q · filed 2016-10-31 | $358.55M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $94.39M 10-K · filed 2017-02-23 | $180.25M 10-Q · filed 2016-08-01 | $258.78M derived: sum of 3 quarters · filed 2017-02-23 | $334.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $85.86M 10-K · filed 2017-02-23 | $164.39M derived: sum of 2 quarters · filed 2017-02-23 | $239.61M derived: sum of 3 quarters · filed 2017-02-23 | $317.06M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $78.53M 10-K · filed 2016-02-16 | $153.75M derived: sum of 2 quarters · filed 2016-02-16 | $231.20M derived: sum of 3 quarters · filed 2016-02-16 | $305.41M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $75.22M 10-K · filed 2016-02-16 | $152.67M derived: sum of 2 quarters · filed 2016-02-16 | $226.88M 10-Q · filed 2015-10-30 | $299.94M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $77.45M 10-K · filed 2016-02-16 | $151.66M 10-Q · filed 2015-08-04 | $224.71M derived: sum of 3 quarters · filed 2016-02-16 | $311.14M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $74.21M 10-K · filed 2016-02-16 | $147.27M derived: sum of 2 quarters · filed 2016-02-16 | $233.69M derived: sum of 3 quarters · filed 2016-02-16 | $338.77M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $73.06M 10-K · filed 2015-02-13 | $75.19M 10-K · filed 2014-02-11 | $159.48M derived: sum of 2 quarters · filed 2015-02-13 | $264.56M derived: sum of 3 quarters · filed 2015-02-13 | $356.19M 10-K · filed 2016-02-16 | $362.34M 10-K · filed 2014-02-11 | ||
| 2013-09-30 | $86.43M 10-K · filed 2015-02-13 | $87.75M 10-Q · filed 2013-11-07 | $191.51M derived: sum of 2 quarters · filed 2015-02-13 | $283.13M 10-Q · filed 2014-11-06 | $287.15M 10-Q · filed 2013-11-07 | $393.58M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-06-30 | $105.08M 10-K · filed 2015-02-13 | $106.52M 10-Q · filed 2013-08-02 | $199.40M 10-Q · filed 2014-07-31 | $307.16M derived: sum of 3 quarters · filed 2015-02-13 | $404.84M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $91.63M 10-K · filed 2015-02-13 | $92.88M 10-Q · filed 2013-05-08 | $202.08M derived: sum of 2 quarters · filed 2015-02-13 | $299.76M derived: sum of 3 quarters · filed 2015-02-13 | $417.27M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | $110.45M 10-K · filed 2014-02-11 | $208.14M derived: sum of 2 quarters · filed 2014-02-11 | $325.65M derived: sum of 3 quarters · filed 2014-02-11 | $432.68M 10-K · filed 2015-02-13 | $436.80M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $97.68M 10-K · filed 2014-02-11 | $215.20M derived: sum of 2 quarters · filed 2014-02-11 | $326.34M 10-Q · filed 2013-11-07 | $448.23M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $117.51M 10-K · filed 2014-02-11 | $228.66M 10-Q · filed 2013-08-02 | $350.54M derived: sum of 3 quarters · filed 2014-02-11 | $461.19M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $111.15M 10-K · filed 2014-02-11 | $233.03M derived: sum of 2 quarters · filed 2014-02-11 | $343.68M derived: sum of 3 quarters · filed 2014-02-11 | $440.34M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $121.88M 10-K · filed 2013-03-01 | $232.53M derived: sum of 2 quarters · filed 2013-03-01 | $329.20M derived: sum of 3 quarters · filed 2013-03-01 | $400.72M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $110.65M 10-K · filed 2013-03-01 | $207.32M derived: sum of 2 quarters · filed 2013-03-01 | $278.84M 10-Q · filed 2012-11-06 | $341.32M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $96.66M 10-K · filed 2013-03-01 | $168.19M 10-Q · filed 2012-08-08 | $230.66M derived: sum of 3 quarters · filed 2013-03-01 | $279.52M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $71.52M 10-K · filed 2013-03-01 | $134.00M derived: sum of 2 quarters · filed 2013-03-01 | $182.86M derived: sum of 3 quarters · filed 2013-03-01 | $223.77M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $62.48M 10-K · filed 2012-02-22 | $111.33M derived: sum of 2 quarters · filed 2012-02-22 | $152.25M derived: sum of 3 quarters · filed 2012-02-22 | $187.80M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $48.85M 10-K · filed 2012-02-22 | $89.77M derived: sum of 2 quarters · filed 2012-02-22 | $125.32M 10-Q · filed 2011-11-03 | $157.90M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $40.91M 10-K · filed 2012-02-22 | $76.47M 10-Q · filed 2011-08-09 | $109.04M derived: sum of 3 quarters · filed 2012-02-22 | $145.61M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $35.55M 10-K · filed 2012-02-22 | $68.13M derived: sum of 2 quarters · filed 2012-02-22 | $104.70M derived: sum of 3 quarters · filed 2012-02-22 | $137.22M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $32.57M 10-K · filed 2011-02-17 | $69.15M derived: sum of 2 quarters · filed 2011-02-17 | $101.67M derived: sum of 3 quarters · filed 2011-02-17 | $130.19M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $36.57M 10-K · filed 2011-02-17 | $69.10M derived: sum of 2 quarters · filed 2011-02-17 | $97.62M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $32.53M 10-K · filed 2011-02-17 | $61.05M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $28.52M 10-K · filed 2011-02-17 | |||||||
| 2008-12-31 | $101.29M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |